Get startedLog in
    Picture of Quantum Genomics SA logo

    ALQGC — Quantum Genomics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Quantum Genomics Signs Exclusive License Agreement With Teva Israel

    Picture of Quantum Genomics SA logoQuantum Genomics SA
    25/11/2021 17:17
    Nov 25 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS SIGNS AN EXCLUSIVE LICENSE AGREEMENT WITH
TEVA
ISRAEL LTD.
    * TEVA WILL RECEIVE AN EXCLUSIVE LICENSE TO BRING FIRIBASTAT
TO
ITS HOME MARKET, ISRAEL
    * QUANTUM GENOMICS WILL RECEIVE PAYMENTS OF UP TO $11 M AND
25%
MINIMUM UP TO 30% ROYALTIES ON FUTURE FIRIBASTAT SALES
    * TEVA WILL RECEIVE EXCLUSIVE MARKETING, SELLING AND
DISTRIBUTION
RIGHTS FOR RESISTANT AND DIFFICULT-TO-TREAT HYPERTENSION IN ITS
HOME MARKET

Source text for Eikon:  ID:nGNXLFf1Z 
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Quantum Genomics SA

    See all news